Overview

Pharmacokinetic Comparison Of All FK-506 Formulations

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetic parameters of three different formulations of tacrolimus. Eligible patients will be treated with all three formulations in a pre-defined sequence.
Phase:
Phase 3
Details
Lead Sponsor:
Veloxis Pharmaceuticals
Treatments:
Tacrolimus